Login / Signup

Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core.

Juliane GrimmRaj BhayadiaLucie GackDirk HecklJan-Henning Klusmann
Published in: Leukemia (2022)
Keyphrases
  • acute myeloid leukemia
  • bone marrow
  • dendritic cells